Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

Trump’s move to withdraw from WHO puts America’s health at ‘grave risk,’ leading medical groups warn

Leaders of the American Medical Association, American Academy of Pediatrics, American Academy of Family Physicians and American College of Physicians all cautioned against the president's plan.

Are 14 hospitals too many for Vermont?

An influential writer in the Green Mountain State who’s lived there since the 1940s is calling for the culling of its hospital network.

Pandemic pushing risky activities into healthcare data management

The COVID crisis has significantly increased the volume of data healthcare providers are rushing into the cloud. This “smash and grab” behavior is largely explained by the spike in healthcare workers doing their jobs remotely.

Thumbnail

AHA condemns Trump administration’s latest attack on ACA

The American Heart Association noted that the Affordable Care Act has provided “invaluable patient protections for millions of Americans with pre-existing conditions.”

Thumbnail

US judge upholds challenge to rule requiring hospitals to post prices

A challenge to a Trump administration rule that requires hospitals to post their prices for services online has been defeated after a U.S. judge granted a summary judgment to HHS.

Thumbnail

Hospitals see minor financial improvement in May

After a brutal two months of significant revenue losses, hospitals saw a slight improvement in margins during May, according to the latest Flash Report from Kaufman Hall.

Thumbnail

CMS adds office to review regulatory and administrative burdens

CMS has announced the formation of the Office of the Burden Reduction and Health Informatics, an organized effort to reduce regulatory and administrative burden and part of the agency’s Patients over Paperwork initiative.

Thumbnail

CMS proposes value-based payment on prescription drugs

CMS has proposed a new rule that aims to enable value-based purchasing agreements across states with drug companies to bring down Medicaid drug prices.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup